Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic

Mehmet Kadri Akboga1, Ugur Canpolat1, Asife Sahinarslan2

  • 1Turkiye Yuksek Ihtisas Education and Research Hospital, Department of Cardiology, Ankara, Turkey.

Atherosclerosis
|March 16, 2015
PubMed

Insights

Higher serum total bilirubin levels are linked to reduced coronary artery disease (CAD) severity and inflammation markers like C-reactive protein (CRP). This suggests bilirubin may have anti-inflammatory effects in atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Inflammation Research

Background:

  • Bilirubin's cardiovascular protective effects are known, primarily attributed to its antioxidant properties.
  • Limited data exists on bilirubin's anti-inflammatory role in cardiovascular disease.
  • Coronary artery disease (CAD) involves complex inflammatory processes.

Purpose of the Study:

  • To investigate the association between serum total bilirubin levels and the severity of stable CAD.
  • To evaluate bilirubin's relationship with inflammatory markers: C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and red cell distribution width (RDW).

Main Methods:

  • Retrospective analysis of angiographic data from 1501 patients with stable CAD.
  • Patients categorized into control, mild CAD, and severe CAD groups based on Gensini scores.
  • Multivariable linear regression analysis used to determine associations between clinical/laboratory parameters and CAD severity.

Main Results:

  • Serum total bilirubin levels were significantly higher in the control group compared to CAD groups.
  • Total bilirubin showed a significant inverse association with CAD severity (β=-3.131, p<0.001).
  • Inverse correlations observed between total bilirubin and CRP (r=-0.112), NLR (r=-0.070), and RDW (r=-0.074).

Conclusions:

  • Serum total bilirubin levels are independently and inversely associated with coronary atherosclerosis severity in stable CAD patients.
  • Higher total bilirubin levels correlate with lower levels of key inflammatory markers (CRP, NLR, RDW).
  • These findings suggest a potential anti-inflammatory role for bilirubin in the coronary atherosclerotic process, beyond its antioxidant effects.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
802
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
879
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
926
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
877
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783